woods randall e  the wall street transcript randall e woods randall e woods is president and chief executive officer of sophiris bio inc mr woods joined sophiris as chief executive officer in august  and brings with him  years of biotech and pharmaceutical leadership experience prior to joining sophiris mr woods was president and ceo of sequel pharmaceuticals a spinout of novacardia developing a potential treatment for atrial fibrillation mr woods was previously the president and ceo of novacardia a pharmaceutical company focused on cardiovascular diseases until its acquisition by merck  co for  million in  prior to novacardia mr woods was president and ceo of corvas international a publicly traded biopharmaceutical company focused on cardiovascular disease and cancer until its acquisition by dendreon in  before joining corvas he served as president of boehringer mannheim’s us pharmaceutical operations and spent  years at eli lilly  company in various sales and marketing positions mr woods is a past chairman for the advisory board of uc san diego’s sulpizio family cardiovascular center and is a past chairman of the board of directors for biocom a life science industry association in southern california mr woods also serves on the board of arena pharmaceuticals he received his bs in biology and chemistry from ball state university and an mba in marketing from western michigan university related interviewsinterview with the president and ceo sophiris bio inc nasdaqsphsaugust  interview with the president and ceo sophiris bio inc sphsapril  randall woods  corvas international inc cvasnovember  randall woods  corvas international inc cvasoctober  randall woods  corvas international inc cvasjanuary  randall e woods  corvas international inc cvasnovember   cartlatest newsjames abate of centre asset management sees consumer demand driving new stock highsmalcolm e polley of stewart capital and how to play the health care stockstimothy biltz ceo of lumos networks identifies the key component for future g networksthe wall street transcript is a completely unique resource for investors and business researchersover  ceo equity analyst and money manager interviewssubscribe nowsign up for newsletter weekly email with new indepth interviews email most popular interviewsdelivering longterm results with a riskmanaged growth fundjames a abate published july   in investing strategiescompanies covered amat jnj coh rl cog nvda adbe atvi klac amzn nflx goog fb glw mu 9  wfm jwn cmg gps eqt rice spls buy finding investments with favorable risk and reward opportunitieshenry beukema published july   in investing strategiescompanies covered orcl msft nsrgy amzn wfm lrlcy agn lnr buy better returns and lower risk in the midcap spacemalcolm e polley published july   in investing strategiescompanies covered praa hurn fii fl nke amzn wfm wba rad buy most popular reportswireless communications  telecom published july  buy investing strategies published july  buy investing strategies published june  buy  top company interviews register for a free account to gain greater access to the wall street transcript right now ceo interviewsinterview with the president and ceo lumos networks corp nasdaqlmosinterview with the corporate vp of business development strategy and investor relations dsp group inc nasdaqdspginterview with the ceo and director tactile systems technology inc nasdaqtcmd sector roundtablesnatural gas weighs heavy on ep nearterm prospectsroundtable forumoptimism despite uncertainty in forprofit educationroundtable foruma shift in focus to natural gas from oil money manager interviewsdelivering longterm results with a riskmanaged growth fundfinding investments with favorable risk and reward opportunitiesbetter returns and lower risk in the midcap space analyst interviewsanalyzing the secular drivers within communications infrastructure and telecomsatellite companies benefiting from growth in data trafficincreased focus on content as consumers shift to digital consumption subscribe today since   the wall street transcript 9 terms and conditions privacy policy   httpswwwtwstcomwpadminadminajaxphp pin it on pinterest share this twitter facebook google gmail linkedin × join now for free already a member first name last name email address  create new account or create an account with a social network join with facebook join with twitter join with google username or email address  password  loginjoin now  forgot password or login using a social network log in with facebook log in with twitter log in with google randall e woods managing director eden woods investments llc timesjavascript is disabled market profiles login sign up login sign up   edit person randall e woods managing director at eden woods investments llc location sunnyvale ca add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop randall e woods managing director at eden woods investments llc location sunnyvale ca add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop prior to founding eden woods investments llc mr woods served as the president and chief executive officer of sequel pharmaceuticals and novacardia a pharmaceutical company that was acquired by merck  co he also was the president and chief executive officer of corvas international inc a nasdaqtraded biotechnology company and president of boehringer mannheim’s us pharmaceutical operations prior mr woods served for more than  years at eli lilly  company in various sales and marketing positions he is the chairman emeritus of the advisory board of the university of california san diego’s sulpizio family cardiovascular center mr woods is also an executive board member and former chairman of biocom a regional life sciences industry association representing southern california mr woods holds a bs in biology and chemistry from ball state university and an mba from western michigan university  companies in career na related markets na colleagues na related investments alias na industry rd in biotech environmental and various industries no marketing product yet tags na topics of influence web site na careers achievements investments related people edit view all randall e woodscareer  jun eden woods investments llc managing director apr sorbent therapeutics chairman of the board board of directors dec arena pharmaceuticals director board of directors competencies edit view all randall e woodseducation  western michigan university marketing  ball state university biologychemistry edit randall e woodsachievements and recognitions add milestone no milestones has been recorded for randall e woods edit randall e woodslinks add link no links has been recorded for randall e woods randall e woodsinvestmentsacquisitions no investments has been recorded for randall e woods randall e woodsinvestments representing others no investment reps has been recorded for randall e woods randall e woodsrelated people view all peers  colin goddard chairman and ceo of coferon inc kathleen sebelius  secretary of us department of health  human services andrew powell general counsel and corporate secretary of medivation kurt graves chairman of the board of radius deborah harland tracy saxton founder and managing partner of pivotal bioventure partners view all randall e woodsrecommended market profiles  telemedicine  or more employees  companies social media marketing chiefmarteccom    employees  companies big data universe list of lists  or more employees  companies aggregated marketing technology  or more employees  companies shared economy landscape jeremiah owyang  or more employees  companies inside sales landscape  or more employees  companies woods randall e  the wall street transcript randall e woods randall e woods joined corvas international inc in may 9 as president chief executive officer and a director prior to joining corvas he served as president of boehringer mannheim’s united states pharmaceutical operations from february 9 to march 9 and as vice president of marketing and sales from december 9 to february 9 previously mr woods served in various sales and marketing capacities at eli lilly  company from  to december 9 related interviews cartlatest newsjames abate of centre asset management sees consumer demand driving new stock highsmalcolm e polley of stewart capital and how to play the health care stockstimothy biltz ceo of lumos networks identifies the key component for future g networksthe wall street transcript is a completely unique resource for investors and business researchersover  ceo equity analyst and money manager interviewssubscribe nowsign up for newsletter weekly email with new indepth interviews email most popular interviewsdelivering longterm results with a riskmanaged growth fundjames a abate published july   in investing strategiescompanies covered amat jnj coh rl cog nvda adbe atvi klac amzn nflx goog fb glw mu 9  wfm jwn cmg gps eqt rice spls buy finding investments with favorable risk and reward opportunitieshenry beukema published july   in investing strategiescompanies covered orcl msft nsrgy amzn wfm lrlcy agn lnr buy better returns and lower risk in the midcap spacemalcolm e polley published july   in investing strategiescompanies covered praa hurn fii fl nke amzn wfm wba rad buy most popular reportswireless communications  telecom published july  buy investing strategies published july  buy investing strategies published june  buy  top company interviews register for a free account to gain greater access to the wall street transcript right now ceo interviewsinterview with the president and ceo lumos networks corp nasdaqlmosinterview with the corporate vp of business development strategy and investor relations dsp group inc nasdaqdspginterview with the ceo and director tactile systems technology inc nasdaqtcmd sector roundtablesnatural gas weighs heavy on ep nearterm prospectsroundtable forumoptimism despite uncertainty in forprofit educationroundtable foruma shift in focus to natural gas from oil money manager interviewsdelivering longterm results with a riskmanaged growth fundfinding investments with favorable risk and reward opportunitiesbetter returns and lower risk in the midcap space analyst interviewsanalyzing the secular drivers within communications infrastructure and telecomsatellite companies benefiting from growth in data trafficincreased focus on content as consumers shift to digital consumption subscribe today since   the wall street transcript 9 terms and conditions privacy policy   httpswwwtwstcomwpadminadminajaxphp pin it on pinterest share this twitter facebook google gmail linkedin × join now for free already a member first name last name email address  create new account or create an account with a social network join with facebook join with twitter join with google username or email address  password  loginjoin now  forgot password or login using a social network log in with facebook log in with twitter log in with google sphs randall e woods insider trades for sophiris bio inc bulletin investor alert new york markets open in market snapshot analyst ratings expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close sophiris bio inc nasdaq sphs go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus sophiris bio inc after hours  quotes are delayed by  min jul    pm sphs quoteszigmancomposite   change  9 volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual randall e woods mr randall e woods is president chief executive officer  director at sophiris bio inc chairman at sorbent therapeutics inc and independent director at arena pharmaceuticals inc he is on the board of directors at sophiris bio inc and arena pharmaceuticals inc mr woods was previously employed as president chief executive officer  director by sequel pharmaceuticals inc president  chief executive officer by novacardia inc president  chief executive officer by corvas international inc president by boehringer mannheim pharmaceuticals corp executive director by biocom and a managerhospital marketing by eli lilly  co he received his undergraduate degree from ball state university indiana and an mba from western michigan university transactions date shares transaction value     acquisition at  per share 9     acquisition at  per share  9    acquisition at  per share      acquisition at  per share      acquisition at 9 per share 9 copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives dr lars g ekman executive chairman mr randall e woods president chief executive officer  director dr allison j hulme coo director  headresearch  development mr peter t slover chief financial officer mr jim l heppell independent director mr gerald t proehl independent director dr john geltosky independent director trending tickers quoteszigman9composite vuzi quoteszigman9composite jcp quoteszigmancomposite nugt9 quoteszigmancomposite tlt quoteszigmancomposite jnug9 x powered by log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest adollar edges higher recovering slightly from recent slide aoil prices move lower as opec meeting gets under way aolympic legend michael phelps loses race against great white shark aairlines oil stocks put ftse  under pressure 9aeuro little changed at  after eurozone pmis for july aeurozone composite pmi at  vs  factset estimate aeurozone services pmi  in july vs  factset estimate aeurozone manufacturing pmi at  in july vs  factset estimate ashares of european automakers fall after cartelclaims report aanglo american platinum swings to loss aanglo american platinum swings to loss afrances cac  opens  higher at  agermanys dax opens  lower at  afrances cac  opens  higher at  auks ftse  opens  lower at  astoxx europe  opens  higher at  atrump to make statement on healthcare monday reports areckitt benckiser profit rises on reduced costs achinese regulator tells insurers to shape up arandgold looks to get more out of tongon mine loading more headlines dow quoteszigman9realtime    nasdaq quoteszigman9realtime    sp  quoteszigmanrealtime  9  kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  forty year industry veteran randall e woods named ceo at sophiris bio  sophiris about management board of directors topsalysin prostate cancer program overview bph program overview clinical trials publications investor relations news events  presentations corporate governance financial information stock information contact investor relations shareholder tools news contact us press releases aug  forty year industry veteran randall e woods named ceo at sophiris bio by sophiris bio news release in press releases no comments san diego california and vancouver british columbia august   — sophiris bio inc tsx shs today announced the appointment of randall e woods as chief executive officer effective august   mr woods brings almost  years of relevant industry experience to sophiris including past roles as ceo at sequel pharmaceuticals novacardia inc and corvas international mr woods takes the helm as sophiris prepares to initiate a pivotal phase  trial for its lead compound prx a highly targeted treatment for benign prostatic hyperplasia bph or enlarged prostate mr woods’ appointment is the final step of an operational realignment that began in  led by executive chairman and president lars ekman md phd to focus on the development of prx for bph since relocating to san diego sophiris has recruited a management team that has achieved more than twenty drug approvals including blockbuster pharmaceuticals “randy’s blend of executive experience in biotech research and development pharmaceutical sales and marketing coupled with successful fundraising and value creation makes him an ideal fit for leading sophiris into the next phase of growth beginning with advancing prx into pivotal trials later this year” said dr lars ekman executive chairman and president of sophiris “nearly every man over the age of  suffers from bph yet current treatments either lack sustained relief of symptoms or come with unwanted side effects” added mr woods “based on the clinical data available to date prx has shown meaningful clinical improvements with an attractive safety profile and presents a very special opportunity for addressing a significant market need for men with bph” prior to joining sophiris mr woods was president and ceo of sequel pharmaceuticals a spinout of novacardia developing a potential treatment for atrial fibrillation mr woods was previously the president and ceo of novacardia a pharmaceutical company focused on cardiovascular diseases until its acquisition by merck  co for  million in  prior to novacardia mr woods was president and ceo of corvas international a publicly held biopharmaceutical company focused on cardiovascular disease and cancer until its acquisition by dendreon in  before joining corvas he served as president of boehringer mannheim’s us pharmaceutical operations and spent  years at eli lilly  company in various sales and marketing positions mr woods is a past chairman for the advisory board of uc san diego’s sulpizio family cardiovascular center and is a past chairman of the board of directors for biocom a life science industry association in southern california mr woods serves on the board of arena pharmaceuticals and is chairman of the board for sorbent therapeutics he received his bs in biology and chemistry from ball state university and an mba in marketing from western michigan university about bph bph is a  billion market with more than  million patients treated each year in the us alone despite available medical treatments and surgical options no single solution provides quick longterm relief of symptoms without serious unwanted side effects pharmaceutical product sales in the us for bph are  billion annually however they lack sustainable efficacy and are associated with undesirable side effects including sexual dysfunction more aggressive treatment options include invasive surgical procedures that may be successful at treating bph but can also result in nerve damage and sexual dysfunction about prx prx is designed to be a single treatment for the longterm relief of bph symptoms such as restricted urinary flow from enlarged prostate without causing sexual dysfunction or sacrificing quality of life prx is highly targeted to prostate tissue it is delivered directly to the prostate tissue via localized injection and it is activated selectively by active prostate specific antigen psa found only in prostate tissue prx has shown meaningful improvements in the international prostate symptom score ipss and urinary flow qmax at  and  months in a randomized controlled phase iib trial triumph study ipss has been a primary endpoint and qmax has been a secondary or coprimary endpoint for prior bph drug approvals to date  patients with bph have been treated with prx and no drug related sexual adverse events have been reported in the studies completed about sophiris sophiris bio inc is a urology company developing a latestage highly targeted treatment for benign prostatic hyperplasia bph or enlarged prostate an unsatisfied market with blockbuster potential prx the company’s lead candidate for bph is designed to be as efficacious as pharmaceuticals less invasive than the surgical interventions and without the sexual side effects seen with existing treatments sophiris is planning to begin a pivotal trial by the end of  sophiris is advised by worldleading urologists backed by experienced investors and led by a team that has achieved more than twenty drug approvals including several blockbusters for more information please visit wwwsophirisbiocom certain statements included in this press release may be considered forwardlooking such statements involve known and unknown risks uncertainties and other factors that may cause actual results performance or achievements to be materially different from those implied by such statements and therefore these statements should not be read as guarantees of future performance or results all forwardlooking statements are based on sophiris’ current beliefs as well as assumptions made by and information currently available to sophiris and relate to among other things anticipated financial performance business prospects strategies regulatory developments market acceptance and future commitments readers are cautioned not to place undue reliance on these forwardlooking statements which speak only as of the date of this press release due to risks and uncertainties including the risks and uncertainties identified by sophiris in its public securities filings actual events may differ materially from current expectations sophiris disclaims any intention or obligation to update or revise any forwardlooking statements whether as a result of new information future events or otherwise for further information contact lauren glaser investor relations the trout group 9 lglasertroutgroupcom james beesley investor relations sequoia partners 9 jamessequoiapartnersca michael moore investor relations equicom group  mmoreequicomgroupcom jason i spark canale communications inc 9 jasoncanalecommcom download full press release » general news » press releases » contact us sharerecommend on facebookshare on linkedintweet about itprint for laterbookmark in browsertell a friend copyright sophiris bio corp  all rights reserved terms and conditions designed by audacity randall e woods  arena pharmaceuticals randall e woods board of directors randall e woods randall e woods has served as a member of our board of directors since december  mr woods has served as the president and chief executive officer of sophiris bio inc a urology company since august  and as a member of its board of directors since october  mr woods served as the president and chief executive officer and a member of the board of directors of sequel pharmaceuticals inc a pharmaceutical company from september  to june  as the president and chief executive officer of novacardia inc a pharmaceutical company that was acquired by merck  co inc from april  to september  as the president and chief executive officer of corvas international inc a biopharmaceutical company from 9 to  in various senior positions at boehringer mannheim’s us pharmaceutical operations from 9 to 9 most recently as president and before then served more than  years at eli lilly  company in sales and marketing positions mr woods is the chairman emeritus of the advisory board of the university of california san diego’s sulpizio cardiovascular center mr woods was the chair of the board of directors of biocom a life science association representing more than  member companies in southern california for 9 mr woods holds a bs in biology and chemistry from ball state university and an mba from western michigan university home about management board of directors pipeline etrasimod ralinepag apd publications collaborations belviq  belviq xr nelotanserin investors press releases eventspresentations analyst coverage corporate governance management board of directors committee composition sec filings quarterly results latest filings investor faqs clinical trials etrasimod ralinepag apd careers randall e woods  southfield mi  intelius sign in we found randall e woods in southfield mi randall e woods intelius found that randall e woods is a male between  and  years old from southfield mi we have connected them to  addresses  phone and  relatives or associates also known as randall s woods get report now age randall e woods is in his s randall has lived in southfield mi detroit mi randalls relatives genise woods shonda newson eric woods richmond woods randall e woods zodiac signscorpio gendermale get report now want to know more about randall get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about randall or use our people search engine to find others get background check on randall e woods get a criminal check on randall e woods get a public record report on randall e woods get a people search report on randall e woods randall e woodss contact information known cities lived in find out where randall e woods has lived as well as randall e woodss phone numbers and email addresses randall e woods has lived in  states michigan address for randall e woods  h c southfield mi has lived in southfield mi detroit mi get full address report phone numbers associated with randall e woods    southfield mi get full phone report email addresses associated with randall e woods get email report randall e woodss social network and potential email matches find out potential social network profiles and potential email usernamed for randall e woods randall e woodss known social networks and potential email matches find all of randall e woodss social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches randall woods username matches randallwoods woodsrandall randallwoods woodsrandall randallwoods woodsrandall randallwoods woodsrandall rwoods popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches r woods intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here insider trading  woods randall e  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  woods randall e select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing sale  pm arena pharmaceuticals inc arna woods randall edirector    direct view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award 9 pm  sophiris bio inc sphs woods randall epresident  chief exec officerdirector 9  9direct view option award  pm na arena pharmaceuticals inc arna woods randall edirector   direct view option award  pm  sophiris bio inc sphs woods randall epresident  chief exec officerdirector   direct view option award  pm nana arena pharmaceuticals inc arna woods randall edirector   direct view exercise  pm nana arena pharmaceuticals inc arna woods randall edirector  9 direct view exercise  pm nana arena pharmaceuticals inc arna woods randall edirector   direct view exercise  pm na arena pharmaceuticals inc arna woods randall edirector  9 direct view exercise  pm na arena pharmaceuticals inc arna woods randall edirector   direct view option award  pm  sophiris bio inc sphs woods randall epresident  chief exec officerdirector 99 9 99direct view   secformcom all rights reserved archives        mon  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  randall woods  sophiris bio inc  zoominfocom wood products atlanta  roswell  buckhead  marietta  johns creek free download   home products   windows   moulding   doors   millwork   columns   decks  porches   lumber   siding   plywood   hardware     services   custom design   delivery           homeowners contractors architects  designers gallery  showroom about us contact us customer resources   stock product guide               wood products for atlanta roswell buckhead marietta johns creek and other communities throughout the southeast no matter what type of wood products your construction renovation or remodeling projects needs randall brothers is sure to have a perfect option in our wide selection our company has been serving the atlanta area for more than  years and offers an exceptional variety of both custom and stock products for contractors designers and homeowners in fact we�re the largest supplier of moulding and millwork in the southeast and have more than  different patterns in stock randall brothers also operates our own woodshop where we can duplicate any sample of wood trim or create custom patterns that will give your project a truly unique look randall brothers� supply of wood products also includes a wide variety of lumber plywood and timbers we have paint and staingrade boards in a variety of popular species including fir cypress poplar red oak mahogany and three varieties of pine so whether you need products for framing decks siding or any other project there�s sure to be an appropriate option in our selection our company also stocks a variety of specialty wood products including pressuretreated lumber kilndried lumber and dblaze� fire resistant boards plus if you�re looking for any sort of exotic species or other specialty wood not in stock we can procure the items you need from one of our many vendors to complete your project randall brothers is also an excellent source for many other wood products including doors windows cedar closet lining cabinetry wood ceiling panels gable vents and more with a wide variety of these items in stock and the ability to offer fast turnaround on custom work there�s no better place to find the outstanding traditional and composite wood products your project needs for more information on our selection or to get a quote on supplies for your next project in atlanta alpharetta sandy springs dunwoody and any other southeastern community contact randall brothers today       randall brothers inc  marietta street nw atlanta ga  monday  friday am  pm tollfree 9 fax  copyright   randall brothers all rights reserved internet marketing by socius marketing inc